Literature DB >> 569586

Single-dose tolerance to antinociception, and physical dependence on beta-endorphin in mice.

J P Huidobro-Toro, E L Way.   

Abstract

beta-Endorphin (B-EN) injected intracerebroventricularly in mice produced a rapid onset, dose-dependent antinociceptive effect. The median analgesic dose (AD50) 30 min following administration was found to be 270 ng/mouse (3.7 nmoles/kg). B-EN produced an acute, single-dose tolerance which was characterized by its dose dependence and the time course of its development. Single-dose tolerance development was demonstrable with doses twice or more the AD50. Tolerance was maximal at about 12 h following the priming dose and disappeared within 48 h. Tolerance was accompanied by some degree of physical dependence as noted by signs of naloxone-precipitated withdrawal similar to those elicitable in the morphine-dependent state. Tolerance development to B-EN was blocked by the simultaneous administration of naloxone and also by pretreatment with 0.35 mg/kg actinomycin D or 30 mg/kg cycloheximide 30 min before B-EN. It appears that single-dose tolerance to B-EN was initiated by processes similar to those involved with tolerance resulting from chronic administration of morphine.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 569586     DOI: 10.1016/0014-2999(78)90204-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  A novel knock-in mouse reveals mechanistically distinct forms of morphine tolerance.

Authors:  Johan Enquist; Joseph A Kim; Selena Bartlett; Madeline Ferwerda; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2011-05-11       Impact factor: 4.030

Review 2.  Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling.

Authors:  María Rodríguez-Muñoz; Javier Garzón
Journal:  Mol Neurobiol       Date:  2013-05-11       Impact factor: 5.590

Review 3.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

4.  Chronic opioid therapy and opioid tolerance: a new hypothesis.

Authors:  Joel S Goldberg
Journal:  Pain Res Treat       Date:  2013-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.